These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33794855)

  • 1. Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients.
    Végh E; Gaál J; Géher P; Gömöri E; Kovács A; Kovács L; Nagy K; Posta EF; Tamási L; Tóth E; Varga E; Domján A; Szekanecz Z; Szűcs G
    BMC Musculoskelet Disord; 2021 Apr; 22(1):325. PubMed ID: 33794855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.
    Fautrel B; Granger B; Combe B; Saraux A; Guillemin F; Le Loet X
    Arthritis Res Ther; 2012 Nov; 14(6):R249. PubMed ID: 23164197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological dissociation of anti-TNF plus methotrexate treatment in early rheumatoid arthritis in routine care: results from the ABRAB study.
    Juhász P; Mester A; Biró AJ; Héjj G; Poór G
    BMC Musculoskelet Disord; 2014 Jul; 15():251. PubMed ID: 25059769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
    Visser K; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Seys PE; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Jul; 69(7):1333-7. PubMed ID: 20498212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.
    Saevarsdottir S; Rezaei H; Geborek P; Petersson I; Ernestam S; Albertsson K; Forslind K; van Vollenhoven RF;
    Ann Rheum Dis; 2015 Aug; 74(8):1509-14. PubMed ID: 24706006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
    Rydell E; Forslind K; Nilsson JÅ; Jacobsson LTH; Turesson C
    Arthritis Res Ther; 2018 May; 20(1):82. PubMed ID: 29720260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort.
    Durnez A; Vanderschueren G; Lateur L; Westhovens R; Verschueren P
    Ann Rheum Dis; 2011 Apr; 70(4):634-7. PubMed ID: 21177296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
    Vanier A; Smolen JS; Allaart CF; Van Vollenhoven R; Verschueren P; Vastesaeger N; Saevarsdottir S; Visser K; Aletaha D; Combe B; Fautrel B
    Rheumatology (Oxford); 2020 Aug; 59(8):1842-1852. PubMed ID: 31722413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
    Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
    Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
    Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
    J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.
    Shiozawa K; Yamane T; Murata M; Yoshihara R; Tsumiyama K; Imura S; Shiozawa S
    Arthritis Res Ther; 2016 Feb; 18():55. PubMed ID: 26922083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.